Viewing Study NCT05744466


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2026-01-25 @ 12:20 AM
Study NCT ID: NCT05744466
Status: RECRUITING
Last Update Posted: 2024-07-23
First Post: 2023-01-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Real-world View
None Deucravacitinib View
None Observational View